GUARDANT HEALTH INC's ticker is GH and the CUSIP is 40131M109. A total of 348 filers reported holding GUARDANT HEALTH INC in Q3 2020. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $5,002 | -100.0% | 213,400 | +143.9% | 0.01% | -58.8% |
Q1 2021 | $13,357,000 | -20.0% | 87,500 | -32.4% | 0.02% | -5.6% |
Q4 2020 | $16,690,000 | +60.3% | 129,500 | +0.9% | 0.02% | +100.0% |
Q2 2020 | $10,409,000 | -49.1% | 128,300 | -60.0% | 0.01% | -47.1% |
Q3 2019 | $20,464,000 | – | 320,600 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 390,945 | $39,102,000 | 11.96% |
Iron Triangle Partners LP | 440,255 | $44,034,000 | 6.14% |
Adalta Capital Management LLC | 110,260 | $11,028,000 | 5.08% |
Ally Bridge Group (NY) LLC | 105,000 | $10,502,000 | 3.67% |
Eagle Health Investments LP | 119,360 | $11,938,000 | 2.91% |
Casdin Capital, LLC | 790,000 | $79,016,000 | 2.23% |
AtonRa Partners | 54,163 | $5,417,000 | 1.88% |
Steadfast Capital Management (UK) Ltd. | 14,686 | $1,469,000 | 1.77% |
STEADFAST CAPITAL MANAGEMENT LP | 1,009,031 | $100,923,000 | 1.66% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 74,500 | $7,451,000 | 1.66% |